ENDRA Life Sciences Inc. NDRA

Set alert

Price alert · NDRA

All alert types
4.80 USD +0.05 +1.05%

At close · Nov 2

4.79 -0.01 -0.21%

After hours · Nov 2, 4:00 PM ET

Bid
4.70 × 2
Ask
4.90 × 2
4.64 Day range 4.89
3.26 52-week range 6.70
YTD
+5.96%
1 year
-8.57%
Open
4.64
Prev close
4.75
Mkt cap
7.20M
Vol
5.78K
Avg vol
31.14K
EPS
-6.33
P/E
0.00
Div yield
0.00%
More statistics
Low
4.64
High
4.89
Forward P/E
-0.02
Beta
0.74
Short ratio
0.05
Inst. own
0.49%
Dividend
0.00
Ex-div date
50-d avg
6.68
200-d avg
291.96
1y target
2,625.00

30m chart

Chart tools
Interval

Built from the cached five-day intraday bars.

Signals (18)
NameTimeAgo
SMA: BullishNov 2, 11:35 AM16 hours ago
MACD: Buy SignalNov 2, 11:35 AM16 hours ago
SMA: BullishNov 2, 10:35 AM17 hours ago
SMA: BearishOct 30, 10:00 AM3 days ago
MACD: Sell SignalOct 30, 10:00 AM3 days ago
SMA: BearishOct 29, 4:00 PM4 days ago
SMA: BullishOct 29, 3:15 PM4 days ago
SMA: BullishOct 29, 3:15 PM4 days ago
SMA: BearishOct 29, 1:45 PM4 days ago
SMA: BearishOct 29, 1:45 PM4 days ago
SMA: BullishOct 29, 12:15 PM4 days ago
SMA: BullishOct 29, 12:15 PM4 days ago
RSI: OverboughtOct 29, 12:15 PM4 days ago
SMA: BearishOct 28, 1:25 PM5 days ago
SMA: BullishOct 28, 11:25 AM5 days ago
SMA: BearishOct 28, 10:25 AM5 days ago
SMA: BullishOct 27, 3:25 PM6 days ago
SMA: BearishOct 27, 2:55 PM6 days ago

Analyst view

Consensus: none

Price target (mean) 2,625.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

NDRA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-143.50-143.50 – -143.50-297.50+51.8%00.0%1
Next quarter-142.80-142.80 – -142.80-455.00+68.6%00.0%1
Current year-1,661.10-1,661.10 – -1,661.10-2,765.00+39.9%00.0%1
Next year-538.30-538.30 – -538.30-1,661.10+67.6%100.00K0.0%1

Upgrades and downgrades

The latest rating changes

NDRA analyst upgrades and downgrades
DateFirmActionFromTo
Jun 7, 2024Ascendiant CapitalMaintainedBuyBuy
Mar 31, 2023HC Wainwright & Co.Reiterated—Buy